Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
MMWR Morb Mortal Wkly Rep
    May 2026
  1. ROLFES MA, Bauck L, Lipton BA, Margrey SF, et al
    Knowledge, Attitudes, and Practices Regarding Avian Influenza Among Owners of Backyard Flocks - United States, July-December 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:234-239.
    >> Share

  2. ROLFES MA, Bauck L, Lipton BA, Margrey SF, et al
    Knowledge, Attitudes, and Practices Regarding Avian Influenza Among Owners of Backyard Flocks - United States, July-December 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:234-239.
    >> Share

  3. KIBIGER L, Oltean HN, Leitz L, Krause E, et al
    Fatal Human Case of Highly Pathogenic Avian Influenza A(H5N5) in a Backyard Flock Owner - Washington, November 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:221-225.
    >> Share

  4. VAUGHAN A, Joyce A, Traub E, Jae M, et al
    Serologic Evidence of Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Veterinary Professional Exposed to an Infected Domestic Cat - Los Angeles County, California, December 2024-January 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:215-220.
    >> Share

    April 2026
  5. BELL JM, Barbre K, Meng L, Lape-Newman B, et al
    Influenza Vaccination Coverage Among Nursing Home Residents and Health Care Personnel - United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2026;75:195-201.
    >> Share

  6. MEGHANI M, Garacci Z, Razzaghi H, de Perio MA, et al
    Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel - United States, 2024-25 Respiratory Virus Season.
    MMWR Morb Mortal Wkly Rep. 2026;75:164-171.
    >> Share

    March 2026
  7. SHAKYA M, Ma KC, Hughes LJ, Smith C, et al
    Early Detection and Surveillance of the SARS-CoV-2 Variant BA.3.2 - Worldwide, November 2024-February 2026.
    MMWR Morb Mortal Wkly Rep. 2026;75:130-137.
    >> Share

  8. MALONEY P, Reeves EL, Wielgosz K, Price AM, et al
    Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026.
    MMWR Morb Mortal Wkly Rep. 2026;75:116-123.
    >> Share

  9. ZHU S, Quint J, Leon TM, Li NJ, et al
    Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - California, October 2025-January 2026.
    MMWR Morb Mortal Wkly Rep. 2026;75:124-128.
    >> Share

    February 2026
  10. SILK BJ, Prill MM, Winn AK, Patton ME, et al
    Respiratory Virus Activity - United States, July 1, 2024-June 30, 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:77-84.
    >> Share

  11. RAYKIN J, Rochin I, Wiegand R, Soto V, et al
    COVID-19 Antiviral Prescription Receipt Among Outpatients Aged >/=65 Years - United States, June 1, 2023-September 30, 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:69-76.
    >> Share

    December 2025
  12. IRVING SA, Rowley EAK, Chickery S, Natarajan K, et al
    Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:607-614.
    >> Share

    November 2025
  13. OLMSTED KE, Ramsey-Omonua T, Thomas ES, Lee JT, et al
    Notes from the Field: Expanding Birthing Hospital Enrollment in the Vaccines for Children Program to Increase Infant Immunization Against Respiratory Syncytial Virus - United States, October 2023-March 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:589-591.
    >> Share

  14. ZAMBRANO LD, Simeone RM, Newhams MM, Payne AB, et al
    Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:580-588.
    >> Share

    September 2025
  15. RUSS S, Nogareda F, Regan AK, Benedetti E, et al
    Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:570-578.
    >> Share

  16. REINHART K, Huang S, Kniss K, Reed C, et al
    Influenza-Associated Pediatric Deaths - United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:565-569.
    >> Share

  17. FAZAL A, Harker EJ, Neelam V, Olson SM, et al
    Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy - United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:556-564.
    >> Share

  18. O'HALLORAN A, Habeck JW, Gilmer M, Threlkel R, et al
    Influenza-Associated Hospitalizations During a High Severity Season - Influenza Hospitalization Surveillance Network, United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:529-537.
    >> Share

  19. TOBOLOWSKY FA, Morris E, Castro L, Schaff T, et al
    Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure - San Francisco, California, December 2024-January 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:522-527.
    >> Share

    August 2025
  20. MOULIA DL, Link-Gelles R, Chu HY, Jamieson D, et al
    Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:508-514.
    >> Share

  21. GROHSKOPF LA, Blanton LH, Ferdinands JM, Reed C, et al
    Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025-26 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:500-507.
    >> Share

  22. BOUNDY EO, Fast H, Jatlaoui TC, Razzaghi H, et al
    Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:484-489.
    >> Share

    June 2025
  23. DIAZ MH, Hersh AL, Olson J, Shah SS, et al
    Mycoplasma pneumoniae Infections in Hospitalized Children - United States, 2018-2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:394-400.
    >> Share

    May 2025
  24. PATTON ME, Moline HL, Whitaker M, Tannis A, et al
    Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:273-281.
    >> Share

    April 2025
  25. JOBE NB, Rose E, Winn AK, Goldstein L, et al
    Human Metapneumovirus Seasonality and Co-Circulation with Respiratory Syncytial Virus - United States, 2014-2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:182-187.
    >> Share

    March 2025
  26. ZHU S, Harriman K, Liu C, Kraushaar V, et al
    Human Cases of Highly Pathogenic Avian Influenza A(H5N1) - California, September-December 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:127-133.
    >> Share

    February 2025
  27. FRUTOS AM, Cleary S, Reeves EL, Ahmad HM, et al
    Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:83-90.
    >> Share

  28. FAZAL A, Reinhart K, Huang S, Kniss K, et al
    Reports of Encephalopathy Among Children with Influenza-Associated Mortality - United States, 2010-11 Through 2024-25 Influenza Seasons.
    MMWR Morb Mortal Wkly Rep. 2025;74:91-95.
    >> Share

  29. FALENDER R, Radniecki TS, Kelly C, Cieslak P, et al
    Avian Influenza A(H5) Subtype in Wastewater - Oregon, September 15, 2021-July 11, 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:102-106.
    >> Share

  30. LINK-GELLES R, Chickery S, Webber A, Ong TC, et al
    Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged >/=18 Years - VISION and IVY Networks, September 2024-January 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:73-82.
    >> Share

  31. NARAHARISETTI R, Weinberg M, Stoddard B, Stobierski MG, et al
    Highly Pathogenic Avian Influenza A(H5N1) Virus Infection of Indoor Domestic Cats Within Dairy Industry Worker Households - Michigan, May 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:61-65.
    >> Share

  32. LEONARD J, Harker EJ, Szablewski CM, Margrey SF, et al
    Notes from the Field: Seroprevalence of Highly Pathogenic Avian Influenza A(H5) Virus Infections Among Bovine Veterinary Practitioners - United States, September 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:50-52.
    >> Share

    January 2025
  33. PAPA A, Barile JP, Jia H, Thompson WW, et al
    Gaps in Mental Health Care-Seeking Among Health Care Providers During the COVID-19 Pandemic - United States, September 2022-May 2023.
    MMWR Morb Mortal Wkly Rep. 2025;74:19-25.
    >> Share

    December 2024
  34. ABDIRIZAK F, Winn AK, Parikh R, Scobie HM, et al
    Surveillance of Human Adenovirus Types and the Impact of the COVID-19 Pandemic on Reporting - United States, 2017-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:1136-1141.
    >> Share

    November 2024
  35. RESES HE, Segovia G, Dubendris H, Barbre K, et al
    Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, November 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1052-1057.
    >> Share

  36. RICHARD DM, Susswein Z, Connolly S, Myers Y Gutierrez A, et al
    Detection of Real-Time Changes in Direction of COVID-19 Transmission Using National- and State-Level Epidemic Trends Based on R(t) Estimates - United States Overall and New Mexico, April-October 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1058-1063.
    >> Share

  37. KRISS JL, Black CL, Razzaghi H, Meghani M, et al
    Influenza, COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1044-1051.
    >> Share

  38. MINTA AA, Ferrari M, Antoni S, Lambert B, et al
    Progress Toward Measles Elimination - Worldwide, 2000-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:1036-1042.
    >> Share

  39. LEFFERTS B, Bressler S, Keck JW, Desnoyers C, et al
    Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children - Yukon-Kuskokwim Delta Region, Alaska, October 2023-June 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1015-1021.
    >> Share

  40. FRUTOS AM, Ahmad HM, Ujamaa D, O'Halloran AC, et al
    Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1022-1029.
    >> Share

  41. MARSHALL KE, Drehoff CC, Alden N, Montoya S, et al
    Personal Protective Equipment Use by Dairy Farmworkers Exposed to Cows Infected with Highly Pathogenic Avian Influenza A(H5N1) Viruses - Colorado, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:999-1003.
    >> Share

  42. MELLIS AM, Coyle J, Marshall KE, Frutos AM, et al
    Serologic Evidence of Recent Infection with Highly Pathogenic Avian Influenza A(H5) Virus Among Dairy Workers - Michigan and Colorado, June-August 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1004-1009.
    >> Share

    October 2024
  43. SUN J, Zhang Y, Zhou S, Song Y, et al
    Laboratory-Confirmed Influenza Hospitalizations During Pregnancy or the Early Postpartum Period - Suzhou City, Jiangsu Province, China, 2018-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:958-964.
    >> Share

  44. JONES CE, Danovaro-Holliday MC, Mwinnyaa G, Gacic-Dobo M, et al
    Routine Vaccination Coverage - Worldwide, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:978-984.
    >> Share

  45. BELL J, Meng L, Barbre K, Wong E, et al
    Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel - National Healthcare Safety Network, United States, 2023-24 Respiratory Virus Season.
    MMWR Morb Mortal Wkly Rep. 2024;73:966-972.
    >> Share

  46. MA KC, Castro J, Lambrou AS, Rose EB, et al
    Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages - United States, May 2023-September 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:938-945.
    >> Share

  47. SEITHER R, Yusuf OB, Dramann D, Calhoun K, et al
    Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2023-24 School Year.
    MMWR Morb Mortal Wkly Rep. 2024;73:925-932.
    >> Share

  48. ZENO EE, Nogareda F, Regan A, Couto P, et al
    Interim Effectiveness Estimates of 2024 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalization - REVELAC-i Network, Five South American Countries, March-July 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:861-868.
    >> Share

  49. TAYLOR CA, Patel K, Pham H, Kirley PD, et al
    COVID-19-Associated Hospitalizations Among U.S. Adults Aged >/=18 Years - COVID-NET, 12 States, October 2023-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:869-875.
    >> Share

  50. QUINLAN CM, Shah MM, DeSantis CE, Bertumen JB, et al
    Differences in COVID-19 Outpatient Antiviral Treatment Among Adults Aged >/=65 Years by Age Group - National Patient-Centered Clinical Research Network, United States, April 2022-September 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:876-882.
    >> Share

    September 2024
  51. HAVERS FP, Whitaker M, Chatwani B, Patton ME, et al
    COVID-19-Associated Hospitalizations and Maternal Vaccination Among Infants Aged <6 Months - COVID-NET, 12 States, October 2022-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:830-836.
    >> Share

  52. HILL HA, Yankey D, Elam-Evans LD, Mu Y, et al
    Decline in Vaccination Coverage by Age 24 Months and Vaccination Inequities Among Children Born in 2020 and 2021 - National Immunization Survey-Child, United States, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:844-853.
    >> Share

  53. RAZZAGHI H, Garacci E, Kahn KE, Lindley MC, et al
    Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:837-843.
    >> Share

  54. PANAGIOTAKOPOULOS L, Moulia DL, Godfrey M, Link-Gelles R, et al
    Use of COVID-19 Vaccines for Persons Aged >/=6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-2025.
    MMWR Morb Mortal Wkly Rep. 2024;73:819-824.
    >> Share

  55. SOELAEMAN RH, Kleven D, Losch J, Vega M, et al
    Notes from the Field: Support for Wastewater Monitoring and Influence on Protective Behavioral Intentions Among Adults - United States, July 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:825-827.
    >> Share

  56. LOUIS S, Mark-Carew M, Biggerstaff M, Yoder J, et al
    Wastewater Surveillance for Influenza A Virus and H5 Subtype Concurrent with the Highly Pathogenic Avian Influenza A(H5N1) Virus Outbreak in Cattle and Poultry and Associated Human Cases - United States, May 12-July 13, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:804-809.
    >> Share

    August 2024
  57. DREHOFF CC, White EB, Frutos AM, Stringer G, et al
    Cluster of Influenza A(H5) Cases Associated with Poultry Exposure at Two Facilities - Colorado, July 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:734-739.
    >> Share

  58. PINGALI C, Yankey D, Chen M, Elam-Evans LD, et al
    National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:708-714.
    >> Share

  59. BRITTON A, Roper LE, Kotton CN, Hutton DW, et al
    Use of Respiratory Syncytial Virus Vaccines in Adults Aged >/=60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:696-702.
    >> Share

  60. AHMAD FB, Cisewski JA, Anderson RN
    Mortality in the United States - Provisional Data, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:677-681.
    >> Share

    July 2024
  61. COYLE J, Bagdasarian N, Eckel S, Kuo J, et al
    Notes from the Field: Health Monitoring, Testing, and Case Identification Among Persons Exposed to Influenza A(H5N1) - Michigan, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:656-658.
    >> Share

    May 2024
  62. HAUSE AM, Moro PL, Baggs J, Zhang B, et al
    Early Safety Findings Among Persons Aged >/=60 Years Who Received a Respiratory Syncytial Virus Vaccine - United States, May 3, 2023-April 14, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:489-494.
    >> Share

  63. GARG S, Reed C, Davis CT, Uyeki TM, et al
    Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:501-505.
    >> Share

  64. CLEMENS T, Moreland B, Mack KA, Thomas K, et al
    Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure - United States, 2019-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:467-473.
    >> Share

  65. TUTTLE A, Hughes CM, Dvorak M, Aeschleman L, et al
    Notes from the Field: Clade II Mpox Surveillance Update - United States, October 2023-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:474-476.
    >> Share

    April 2024
  66. SMITH-JEFFCOAT SE, Mellis AM, Grijalva CG, Talbot HK, et al
    SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:365-371.
    >> Share

  67. PANAGIOTAKOPOULOS L, Godfrey M, Moulia DL, Link-Gelles R, et al
    Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged >/=65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:377-381.
    >> Share

  68. ZAMBRANO LD, Newhams MM, Simeone RM, Payne AB, et al
    Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:330-338.
    >> Share

  69. FRANKLIN D, Barbre K, Rowe TA, Reses HE, et al
    COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National Healthcare Safety Network, United States, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:339-344.
    >> Share

  70. LIKO J, Cieslak PR
    Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:317-320.
    >> Share

  71. DOSHI RH, Nsasiirwe S, Dahlke M, Atagbaza A, et al
    COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:307-311.
    >> Share

  72. EL KALACH R, Jones-Jack N, Elam MA, Olorukooba A, et al
    Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics - United States, September 1, 2022-September 30, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:286-290.
    >> Share

    March 2024
  73. LINK-GELLES R, Rowley EAK, DeSilva MB, Dascomb K, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged >/=18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:271-276.
    >> Share

  74. WILLIAMS SL, Smith DJ, Benedict K, Ahlers JR, et al
    Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis During the COVID-19 Pandemic - United States, 2019-2021.
    MMWR Morb Mortal Wkly Rep. 2024;73:239-244.
    >> Share

  75. YOUSAF AR, Lindsey KN, Wu MJ, Shah AB, et al
    Notes from the Field: Surveillance for Multisystem Inflammatory Syndrome in Children - United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:225-228.
    >> Share

  76. MOLINE HL, Tannis A, Toepfer AP, Williams JV, et al
    Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:209-214.
    >> Share

    February 2024
  77. ZHU S, Quint J, Leon TM, Sun M, et al
    Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza - California, October 2023-January 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:175-179.
    >> Share

  78. FRUTOS AM, Price AM, Harker E, Reeves EL, et al
    Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
    MMWR Morb Mortal Wkly Rep. 2024;73:168-174.
    >> Share

  79. DECUIR J, Payne AB, Self WH, Rowley EAK, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged >/=18 Years - VISION and IVY Networks,
    MMWR Morb Mortal Wkly Rep. 2024;73:180-188.
    >> Share

  80. ESSER MB, Sherk A, Liu Y, Naimi TS, et al
    Deaths from Excessive Alcohol Use - United States, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2024;73:154-161.
    >> Share

  81. EDENS C, Clopper BR, DeVies J, Benitez A, et al
    Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:149-151.
    >> Share

  82. MUSA N, Ghoniem A, Hsu CH, Mubarak S, et al
    Progress Toward Measles Elimination - World Health Organization Eastern Mediterranean Region, 2019-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:139-144.
    >> Share

  83. FORD ND, Agedew A, Dalton AF, Singleton J, et al
    Notes from the Field: Long COVID Prevalence Among Adults - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:135-136.
    >> Share

  84. LINK-GELLES R, Ciesla AA, Mak J, Miller JD, et al
    Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Pro
    MMWR Morb Mortal Wkly Rep. 2024;73:77-83.
    >> Share

    January 2024
  85. MONACH PA, Anand ST, Fillmore NR, La J, et al
    Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 - Veterans Health Administration, March-September 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:57-61.
    >> Share

  86. PAYNE AB, Novosad S, Wiegand RE, Najdowski M, et al
    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged >/=65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:16-23.
    >> Share

    December 2023
  87. BLACK CL, Kriss JL, Razzaghi H, Patel SA, et al
    Influenza, Updated COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1377-1382.
    >> Share

  88. RESES HE, Dubendris H, Haas L, Barbre K, et al
    Coverage with Influenza, Respiratory Syncytial Virus, and Updated COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, December 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1371-1376.
    >> Share

  89. HARRINGTON PR, Cong J, Troy SB, Rawson JMO, et al
    Evaluation of SARS-CoV-2 RNA Rebound After Nirmatrelvir/Ritonavir Treatment in Randomized, Double-Blind, Placebo-Controlled Trials - United States and International Sites, 2021-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1365-1370.
    >> Share

  90. SMITH DJ, Lambrou A, Patel P
    SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals.
    MMWR Morb Mortal Wkly Rep. 2023;72:1357-1364.
    >> Share

  91. SPENCER H, Jorgensen E, Seo J, Robinson C, et al
    Notes from the Field: COVID-19 Pandemic-Related Changes in Blood Lead Screening - Chicago, Illinois, 2017-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1353-1354.
    >> Share


  92. QuickStats: Age-Adjusted Percentage* of Adults Aged >/=18 Years Who Received an Influenza Vaccination During the Past 12 Months,(dagger) by Sex and Race and Ethnicity( section sign) - National Health Interview Survey, United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1313.
    >> Share

  93. TANNIS A, Englund JA, Perez A, Harker EJ, et al
    SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months-4 Years - New Vaccine Surveillance Network, United States, July 2022-September 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1300-1306.
    >> Share

    November 2023
  94. CEJTIN HE, Warren EF, Guidry T, Boss K, et al
    Notes from the Field: Diagnosis of Congenital Syphilis and Syphilis Among Females of Reproductive Age Before and During the COVID-19 Pandemic - Chicago, 2015-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1288-1289.
    >> Share

  95. MINTA AA, Ferrari M, Antoni S, Portnoy A, et al
    Progress Toward Measles Elimination - Worldwide, 2000-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1262-1268.
    >> Share

  96. BELL J, Meng L, Barbre K, Haanschoten E, et al
    Influenza and Up-to-Date COVID-19 Vaccination Coverage Among Health Care Personnel - National Healthcare Safety Network, United States, 2022-23 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2023;72:1237-1243.
    >> Share

  97. LYMON H, Meng L, Reses HE, Barbre K, et al
    Declines in Influenza Vaccination Coverage Among Health Care Personnel in Acute Care Hospitals During the COVID-19 Pandemic - United States, 2017-2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1244-1247.
    >> Share

  98. SEITHER R, Yusuf OB, Dramann D, Calhoun K, et al
    Coverage with Selected Vaccines and Exemption from School Vaccine Requirements Among Children in Kindergarten - United States, 2022-23 School Year.
    MMWR Morb Mortal Wkly Rep. 2023;72:1217-1224.
    >> Share

    October 2023
  99. LAMBROU AS, South E, Ballou ES, Paden CR, et al
    Early Detection and Surveillance of the SARS-CoV-2 Variant BA.2.86 - Worldwide, July-October 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1162-1167.
    >> Share

  100. BART SM, Rothstein AP, Philipson CW, Smith TC, et al
    Notes from the Field: Early Identification of the SARS-CoV-2 Omicron BA.2.86 Variant by the Traveler-Based Genomic Surveillance Program - Dulles International Airport, August 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1168-1169.
    >> Share

  101. CHACKO S, Kamal M, Hastuti EB, Mildya F, et al
    Progress Toward Measles and Rubella Elimination - Indonesia, 2013-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1134-1139.
    >> Share

  102. REGAN JJ, Moulia DL, Link-Gelles R, Godfrey M, et al
    Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged >/=6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1140-1146.
    >> Share

  103. WHITE EB, O'Halloran A, Sundaresan D, Gilmer M, et al
    High Influenza Incidence and Disease Severity Among Children and Adolescents Aged <18 Years - United States, 2022-23 Season.
    MMWR Morb Mortal Wkly Rep. 2023;72:1108-1114.
    >> Share

  104. FLEMING-DUTRA KE, Jones JM, Roper LE, Prill MM, et al
    Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - Unite
    MMWR Morb Mortal Wkly Rep. 2023;72:1115-1122.
    >> Share

  105. SURIE D, Yuengling KA, DeCuir J, Zhu Y, et al
    Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged >/=60 Years - IVY Network, 20 U.S. States, February 2022-May 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1083-1088.
    >> Share

  106. HAVERS FP, Whitaker M, Melgar M, Chatwani B, et al
    Characteristics and Outcomes Among Adults Aged >/=60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus - RSV-NET, 12 States, July 2022-June 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1075-1082.
    >> Share

  107. HAANSCHOTEN E, Dubendris H, Reses HE, Barbre K, et al
    Disparities in COVID-19 Vaccination Status Among Long-Term Care Facility Residents - United States, October 31, 2022-May 7, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1095-1098.
    >> Share

  108. TAYLOR CA, Patel K, Patton ME, Reingold A, et al
    COVID-19-Associated Hospitalizations Among U.S. Adults Aged >/=65 Years - COVID-NET, 13 States, January-August 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1089-1094.
    >> Share

    September 2023
  109. RAZZAGHI H, Kahn KE, Calhoun K, Garacci E, et al
    Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women - United States, April 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1065-1071.
    >> Share

  110. SHEPHARD HM, Manning SE, Nestoridi E, Darling AM, et al
    Inequities in COVID-19 Vaccination Coverage Among Pregnant Persons, by Disaggregated Race and Ethnicity - Massachusetts, May 2021-October 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1052-1056.
    >> Share

  111. MEGHANI M, Salvesen Von Essen B, Zapata LB, Polen K, et al
    COVID-19 Vaccination Recommendations and Practices for Women of Reproductive Age by Health Care Providers - Fall DocStyles Survey, United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1045-1051.
    >> Share

  112. SIMEONE RM, Zambrano LD, Halasa NB, Fleming-Dutra KE, et al
    Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1057-1064.
    >> Share

  113. FOWLKES AL, Nogareda F, Regan A, Loayza S, et al
    Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1010-1015.
    >> Share

  114. DEJONGE PM, Adams C, Pray I, Schussman MK, et al
    Wastewater Surveillance Data as a Complement to Emergency Department Visit Data for Tracking Incidence of Influenza A and Respiratory Syncytial Virus - Wisconsin, August 2022-March 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1005-1009.
    >> Share

  115. MASRESHA BG, Hatcher C, Lebo E, Tanifum P, et al
    Progress Toward Measles Elimination - African Region, 2017-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:985-991.
    >> Share

    August 2023
  116. JONES JM, Fleming-Dutra KE, Prill MM, Roper LE, et al
    Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:920-925.
    >> Share

  117. PINGALI C, Yankey D, Elam-Evans LD, Markowitz LE, et al
    Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:912-919.
    >> Share

  118. LINK-GELLES R, Ciesla AA, Rowley EAK, Klein NP, et al
    Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:886-892.
    >> Share

  119. NAVARRETE J, Barone G, Qureshi I, Woods A, et al
    SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During Delta and Early Omicron Waves - United States, June 30, 2021-September 27, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:871-876.
    >> Share

  120. FORD ND, Slaughter D, Edwards D, Dalton A, et al
    Long COVID and Significant Activity Limitation Among Adults, by Age - United States, June 1-13, 2022, to June 7-19, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:866-870.
    >> Share

  121. MONTOY JCC, Ford J, Yu H, Gottlieb M, et al
    Prevalence of Symptoms
    MMWR Morb Mortal Wkly Rep. 2023;72:859-865.
    >> Share

  122. ROMANSON B, Moro PL, Su JR, Marquez P, et al
    Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged >/=12 Years - United States, July 13, 2022-March 13, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:850-851.
    >> Share

    July 2023

  123. QuickStats: Percentage* of Adults Aged >/=18 Years who Received an Influenza Vaccination in the Past 12 Months,(dagger) by Race and Ethnicity( section sign) and Family Income( paragraph sign) - National Health Interview Survey, United States, 2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:836.
    >> Share

  124. MELGAR M, Britton A, Roper LE, Talbot HK, et al
    Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:793-801.
    >> Share

  125. KABORE HJ, Li X, Alleman MM, Manzengo CM, et al
    Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - World Health Organization African Region, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:782-787.
    >> Share

  126. NAVON L, Yuan K, Beck L
    Notes from the Field: Emergency Department Visits for Nonfatal Pedal Cyclist Injuries Before and During the COVID-19 Pandemic, United States, 2019-2020.
    MMWR Morb Mortal Wkly Rep. 2023;72:769-771.
    >> Share

  127. ROEHLER DR, Smith H 4th, Radhakrishnan L, Holland KM, et al
    Cannabis-Involved Emergency Department Visits Among Persons Aged <25 Years Before and During the COVID-19 Pandemic - United States, 2019-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:758-765.
    >> Share

  128. KAUR G, Casey RM, Patel JC, Bloem P, et al
    Status of New Vaccine Introduction - Worldwide, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:746-750.
    >> Share

    June 2023
  129. MASTERSON JM, Luu M, Dallas KB, Daskivich LP, et al
    Disparities in COVID-19 Disease Incidence by Income and Vaccination Coverage - 81 Communities, Los Angeles, California, July 2020-September 2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:728-731.
    >> Share

  130. DELAHOY MJ, Shah HJ, Weller DL, Ray LC, et al
    Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:701-706.
    >> Share

  131. ALI FRM, Seidenberg AB, Crane E, Seaman E, et al
    E-cigarette Unit Sales by Product and Flavor Type, and Top-Selling Brands, United States, 2020-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:672-677.
    >> Share

  132. MA KC, Dorabawila V, Leon TM, Henry H, et al
    Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged >/=18 Years - 18 U.S. Jurisdictions, September 2021-December 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:683-689.
    >> Share

  133. WONG E, Barbre K, Wiegand RE, Reses HE, et al
    Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents - United States, November 20, 2022-January 8, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:690-693.
    >> Share

  134. JOHNSON AG, Linde L, Payne AB, Ali AR, et al
    Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged >/=65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months - 20 U.S. Jurisdictions, September 18, 2022-April 1, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:667-669.
    >> Share

  135. MOULIA DL, Wallace M, Roper LE, Godfrey M, et al
    Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged >/=6 Months - United States, April 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:657-662.
    >> Share

  136. MA KC, Shirk P, Lambrou AS, Hassell N, et al
    Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:651-656.
    >> Share

  137. HAUSE AM, Marquez P, Zhang B, Moro PL, et al
    Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:621-626.
    >> Share

  138. STEHLING-ARIZA T, Wilkinson AL, Diop OM, Jorba J, et al
    Surveillance To Track Progress Toward Poliomyelitis Eradication - Worldwide, 2021-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:613-620.
    >> Share

  139. JONES JM, Manrique IM, Stone MS, Grebe E, et al
    Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:601-605.
    >> Share

    May 2023
  140. LINK-GELLES R, Weber ZA, Reese SE, Payne AB, et al
    Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:579-588.
    >> Share

  141. SCOBIE HM, Panaggio M, Binder AM, Gallagher ME, et al
    Correlations and Timeliness of COVID-19 Surveillance Data Sources and Indicators - United States, October 1, 2020-March 22, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:529-535.
    >> Share

  142. SILK BJ, Scobie HM, Duck WM, Palmer T, et al
    COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration - United States, May 11, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:523-528.
    >> Share

  143. ANDERSON KN, Johns D, Holland KM, Chen Y, et al
    Emergency Department Visits Involving Mental Health Conditions, Suicide-Related Behaviors, and Drug Overdoses Among Adolescents - United States, January 2019-February 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:502-512.
    >> Share

  144. AHMAD FB, Cisewski JA, Xu J, Anderson RN, et al
    COVID-19 Mortality Update - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:493-496.
    >> Share

  145. AHMAD FB, Cisewski JA, Xu J, Anderson RN, et al
    Provisional Mortality Data - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:488-492.
    >> Share

    April 2023
  146. DECUIR J, Surie D, Zhu Y, Gaglani M, et al
    Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31
    MMWR Morb Mortal Wkly Rep. 2023;72:463-468.
    >> Share

  147. LUISI N, Sullivan PS, Sanchez T, Bradley H, et al
    Use of COVIDTests.gov At-Home Test Kits Among Adults in a National Household Probability Sample - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:445-449.
    >> Share

  148. ELAM-EVANS LD, Jones CP, Vashist K, Yankey D, et al
    The Association of Reported Experiences of Racial and Ethnic Discrimination in Health Care with COVID-19 Vaccination Status and Intent - United States, April 22, 2021-November 26, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:437-444.
    >> Share

  149. YANG Q, Tong X, Schieb L, Coronado F, et al
    Stroke Mortality Among Black and White Adults Aged >/=35 Years Before and During the COVID-19 Pandemic - United States, 2015-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:431-436.
    >> Share

  150. FARAH R, Rege SV, Cole RJ, Holstege CP, et al
    Suspected Suicide Attempts by Self-Poisoning Among Persons Aged 10-19 Years During the COVID-19 Pandemic - United States, 2020-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:426-430.
    >> Share

  151. MARK-CAREW M, Kang G, Pampati S, Mead KR, et al
    Ventilation Improvements Among K-12 Public School Districts - United States, August-December 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:372-376.
    >> Share

  152. HAMID S, Winn A, Parikh R, Jones JM, et al
    Seasonality of Respiratory Syncytial Virus - United States, 2017-2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:355-361.
    >> Share

    March 2023
  153. DANIELSON ML, Bohm MK, Newsome K, Claussen AH, et al
    Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults - United States, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:327-332.
    >> Share

  154. ZWALD ML, Van Dyke ME, Chen MS, Radhakrishnan L, et al
    Emergency Department Visits for Firearm Injuries Before and During the COVID-19 Pandemic - United States, January 2019-December 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:333-337.
    >> Share

  155. STALTER RM, Pecha M, Dov L, Miller D, et al
    Tuberculosis Outbreak in a State Prison System - Washington, 2021-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:309-312.
    >> Share

  156. GOMARE MD, Bhide S, Deshmukh R, Kaipilyawar S, et al
    Retaining Patients with Drug-Resistant Tuberculosis on Treatment During the COVID-19 Pandemic - Dharavi, Mumbai, India, 2020-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:304-308.
    >> Share

  157. SCHILDKNECHT KR, Pratt RH, Feng PI, Price SF, et al
    Tuberculosis - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:297-303.
    >> Share

  158. FAIRLIE T, Chu B, Thomas ES, Querns AK, et al
    School-Based Interventions to Increase Student COVID-19 Vaccination Coverage in Public School Populations with Low Coverage - Seattle, Washington, December 2021-June 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:283-287.
    >> Share


  159. Correction and Republication: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, Sept
    MMWR Morb Mortal Wkly Rep. 2023;72:292.
    >> Share

  160. TENFORDE MW, Weber ZA, Natarajan K, Klein NP, et al
    Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
    MMWR Morb Mortal Wkly Rep. 2023;71:1637-1646.
    >> Share

  161. PECK ME, Ong KS, Lucas T, Harvey P, et al
    Voluntary Medical Male Circumcisions for HIV Prevention - 13 Countries in Eastern and Southern Africa, 2017-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:256-260.
    >> Share

    February 2023
  162. LUOMA E, Rohrer R, Parton H, Hughes S, et al
    Notes from the Field: Epidemiologic Characteristics of SARS-CoV-2 Recombinant Variant XBB.1.5 - New York City, November 1, 2022-January 4, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:212-214.
    >> Share

  163. BART SM, Smith TC, Guagliardo SAJ, Walker AT, et al
    Effect of Predeparture Testing on Postarrival SARS-CoV-2-Positive Test Results Among International Travelers - CDC Traveler-Based Genomic Surveillance Program, Four U.S. Airports, March-September 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:206-209.
    >> Share

  164. MORFINO RC, Bart SM, Franklin A, Rome BH, et al
    Notes from the Field: Aircraft Wastewater Surveillance for Early Detection of SARS-CoV-2 Variants - John F. Kennedy International Airport, New York City, August-September 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:210-211.
    >> Share

    April 2020
  165. GARG S, Kim L, Whitaker M, O'Halloran A, et al
    Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:458-464.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016